SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-018294
Filing Date
2016-05-06
Accepted
2016-05-06 16:31:19
Documents
47
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atra-10q_20160331.htm 10-Q 1705895
2 EX-10.1 atra-ex101_660.htm EX-10.1 84050
3 EX-31.1 atra-ex311_10.htm EX-31.1 14880
4 EX-31.2 atra-ex312_9.htm EX-31.2 14902
5 EX-32.1 atra-ex321_8.htm EX-32.1 7766
  Complete submission text file 0001564590-16-018294.txt   5243104

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT atra-20160331.xml EX-101.INS 1087270
7 XBRL TAXONOMY EXTENSION SCHEMA atra-20160331.xsd EX-101.SCH 30756
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atra-20160331_cal.xml EX-101.CAL 37591
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atra-20160331_def.xml EX-101.DEF 88444
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20160331_lab.xml EX-101.LAB 273890
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20160331_pre.xml EX-101.PRE 195686
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 161628541
SIC: 2836 Biological Products, (No Diagnostic Substances)